Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 110

1.

Protection against autoimmune diabetes by silkworm-produced GFP-tagged CTB-insulin fusion protein.

Meng Q, Wang W, Shi X, Jin Y, Zhang Y.

Clin Dev Immunol. 2011;2011:831704. doi: 10.1155/2011/831704. Epub 2011 Jun 6.

PMID:
21765853
[PubMed - indexed for MEDLINE]
Free PMC Article
2.
3.

Oral administration of a cholera toxin B subunit-insulin fusion protein produced in silkworm protects against autoimmune diabetes.

Gong Z, Jin Y, Zhang Y.

J Biotechnol. 2005 Sep 22;119(1):93-105.

PMID:
16024127
[PubMed - indexed for MEDLINE]
4.

The cholera toxin B subunit is a mucosal adjuvant for oral tolerance induction in type 1 diabetes.

Bregenholt S, Wang M, Wolfe T, Hughes A, Baerentzen L, Dyrberg T, von Herrath MG, Petersen JS.

Scand J Immunol. 2003 May;57(5):432-8.

PMID:
12753499
[PubMed - indexed for MEDLINE]
5.

Production of a recombinant cholera toxin B subunit-insulin B chain peptide hybrid protein by Brevibacillus choshinensis expression system as a nasal vaccine against autoimmune diabetes.

Yuki Y, Hara-Yakoyama C, Guadiz AA, Udaka S, Kiyono H, Chatterjee S.

Biotechnol Bioeng. 2005 Dec 30;92(7):803-9.

PMID:
16142801
[PubMed - indexed for MEDLINE]
6.

Oral administration of cholera toxin B-insulin conjugates protects NOD mice from autoimmune diabetes by inducing CD4+ regulatory T-cells.

Ploix C, Bergerot I, Durand A, Czerkinsky C, Holmgren J, Thivolet C.

Diabetes. 1999 Nov;48(11):2150-6.

PMID:
10535448
[PubMed - indexed for MEDLINE]
Free Article
7.

Nasal administration of CTB-insulin induces active tolerance against autoimmune diabetes in non-obese diabetic (NOD) mice.

Aspord C, Thivolet C.

Clin Exp Immunol. 2002 Nov;130(2):204-11.

PMID:
12390307
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Glutamic acid decarboxylase epitope protects against autoimmune diabetes through activation of Th2 immune response and induction of possible regulatory mechanism.

Gong Z, Pan L, Le Y, Liu Q, Zhou M, Xing W, Zhuo R, Wang S, Guo J.

Vaccine. 2010 May 28;28(24):4052-8. doi: 10.1016/j.vaccine.2010.04.005. Epub 2010 Apr 18.

PMID:
20406664
[PubMed - indexed for MEDLINE]
9.

Suppression of hyperglycemia in NOD mice after inoculation with recombinant vaccinia viruses.

Dénes B, Yu J, Fodor N, Takátsy Z, Fodor I, Langridge WH.

Mol Biotechnol. 2006 Nov;34(3):317-27.

PMID:
17284779
[PubMed - indexed for MEDLINE]
10.

Protection of NOD mice from type 1 diabetes after oral inoculation with vaccinia viruses expressing adjuvanted islet autoantigens.

Denes B, Krausova V, Fodor N, Timiryasova T, Henderson D, Hough J, Yu J, Fodor I, Langridge WH.

J Immunother. 2005 Sep-Oct;28(5):438-48.

PMID:
16113600
[PubMed - indexed for MEDLINE]
11.

A cholera toxoid-insulin conjugate as an oral vaccine against spontaneous autoimmune diabetes.

Bergerot I, Ploix C, Petersen J, Moulin V, Rask C, Fabien N, Lindblad M, Mayer A, Czerkinsky C, Holmgren J, Thivolet C.

Proc Natl Acad Sci U S A. 1997 Apr 29;94(9):4610-4.

PMID:
9114038
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cholera toxin subunit B peptide fusion proteins reveal impaired oral tolerance induction in diabetes-prone but not in diabetes-resistant mice.

Presa M, Ortiz AZ, Garabatos N, Izquierdo C, Rivas EI, Teyton L, Mora C, Serreze D, Stratmann T.

Eur J Immunol. 2013 Nov;43(11):2969-79. doi: 10.1002/eji.201343633. Epub 2013 Aug 27.

PMID:
23925934
[PubMed - indexed for MEDLINE]
13.

Suppression of dendritic cell activation by diabetes autoantigens linked to the cholera toxin B subunit.

Odumosu O, Payne K, Baez I, Jutzy J, Wall N, Langridge W.

Immunobiology. 2011 Apr;216(4):447-56. doi: 10.1016/j.imbio.2010.09.008. Epub 2010 Sep 24.

PMID:
20956025
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

A plant-based cholera toxin B subunit-insulin fusion protein protects against the development of autoimmune diabetes.

Arakawa T, Yu J, Chong DK, Hough J, Engen PC, Langridge WH.

Nat Biotechnol. 1998 Oct;16(10):934-8.

PMID:
9788349
[PubMed - indexed for MEDLINE]
15.

Genetic fusion of human insulin B-chain to the B-subunit of cholera toxin enhances in vitro antigen presentation and induction of bystander suppression in vivo.

Sadeghi H, Bregenholt S, Wegmann D, Petersen JS, Holmgren J, Lebens M.

Immunology. 2002 Jun;106(2):237-45.

PMID:
12047753
[PubMed - indexed for MEDLINE]
Free PMC Article
16.

Expression of cholera toxin B-proinsulin fusion protein in lettuce and tobacco chloroplasts--oral administration protects against development of insulitis in non-obese diabetic mice.

Ruhlman T, Ahangari R, Devine A, Samsam M, Daniell H.

Plant Biotechnol J. 2007 Jul;5(4):495-510. Epub 2007 May 9.

PMID:
17490448
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

B lymphocytes promote expansion of regulatory T cells in oral tolerance: powerful induction by antigen coupled to cholera toxin B subunit.

Sun JB, Flach CF, Czerkinsky C, Holmgren J.

J Immunol. 2008 Dec 15;181(12):8278-87.

PMID:
19050244
[PubMed - indexed for MEDLINE]
Free Article
18.

B lymphocytes treated in vitro with antigen coupled to cholera toxin B subunit induce antigen-specific Foxp3(+) regulatory T cells and protect against experimental autoimmune encephalomyelitis.

Sun JB, Czerkinsky C, Holmgren J.

J Immunol. 2012 Feb 15;188(4):1686-97. doi: 10.4049/jimmunol.1101771. Epub 2012 Jan 16.

PMID:
22250081
[PubMed - indexed for MEDLINE]
Free Article
19.

Oral tolerance induction with antigen conjugated to cholera toxin B subunit generates both Foxp3+CD25+ and Foxp3-CD25- CD4+ regulatory T cells.

Sun JB, Raghavan S, Sjöling A, Lundin S, Holmgren J.

J Immunol. 2006 Dec 1;177(11):7634-44.

PMID:
17114433
[PubMed - indexed for MEDLINE]
Free Article
20.

Immunotherapy of autoimmune diabetes by nasal administration of tandem glutamic acid decarboxylase 65 peptides.

Wang H, Yang J, Jin L, Feng J, Lu Y, Sun Y, Li T, Cao R, Wu J, Fan H, Liu J.

Immunol Invest. 2009;38(8):690-703. doi: 10.3109/08820130903124770.

PMID:
19860582
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk